These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder. O'Driscoll GA; Dépatie L; Holahan AL; Savion-Lemieux T; Barr RG; Jolicoeur C; Douglas VI Biol Psychiatry; 2005 Jun; 57(11):1452-60. PubMed ID: 15950020 [TBL] [Abstract][Full Text] [Related]
23. [Psychiatric comorbidity related to children with attention deficit hyperactivity disorder at schools in Sfax, Tunisia]. Khemakhem K; Ayedi H; Moalla Y; Yaich S; Hadjkacem I; Walha A; Damak J; Ghribi F Encephale; 2015 Feb; 41(1):56-61. PubMed ID: 25439858 [TBL] [Abstract][Full Text] [Related]
24. Attention deficit hyperactivity disorder (ADHD) and executive functioning in affected and unaffected adolescents and their parents: challenging the endophenotype construct. Thissen AJ; Rommelse NN; Hoekstra PJ; Hartman C; Heslenfeld D; Luman M; van Lieshout M; Franke B; Oosterlaan J; Buitelaar JK Psychol Med; 2014 Mar; 44(4):881-92. PubMed ID: 23721667 [TBL] [Abstract][Full Text] [Related]
25. [Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department]. Kooij JJ; Aeckerlin LP; Buitelaar JK Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1498-501. PubMed ID: 11512422 [TBL] [Abstract][Full Text] [Related]
26. School dysfunction in youth with autistic spectrum disorder in Taiwan: The effect of subtype and ADHD. Chiang HL; Kao WC; Chou MC; Chou WJ; Chiu YN; Wu YY; Gau SS Autism Res; 2018 Jun; 11(6):857-869. PubMed ID: 29427542 [TBL] [Abstract][Full Text] [Related]
27. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample. Yang P; Hsu HY; Chiou SS; Chao MC Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272 [TBL] [Abstract][Full Text] [Related]
28. Disturbed microstructural integrity of the frontostriatal fiber pathways and executive dysfunction in children with attention deficit hyperactivity disorder. Shang CY; Wu YH; Gau SS; Tseng WY Psychol Med; 2013 May; 43(5):1093-107. PubMed ID: 22894768 [TBL] [Abstract][Full Text] [Related]
29. [Executive functions and stressful characteristics of children with attention-deficit hyperactivity disorder: influence on behavioral problems during adolescence]. Colomer-Diago C; Miranda-Casas A; Herdoiza-Arroyo P; Presentación-Herrero MJ Rev Neurol; 2012 Feb; 54 Suppl 1():S117-26. PubMed ID: 22374763 [TBL] [Abstract][Full Text] [Related]
30. The relationship between attention, executive functions and reading domain abilities in attention deficit hyperactivity disorder and reading disorder: a comparative study. Bental B; Tirosh E J Child Psychol Psychiatry; 2007 May; 48(5):455-63. PubMed ID: 17501726 [TBL] [Abstract][Full Text] [Related]
31. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1? Payne JM; Arnold SS; Pride NA; North KN Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611 [TBL] [Abstract][Full Text] [Related]
32. Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. Brown TE; Brams M; Gao J; Gasior M; Childress A Postgrad Med; 2010 Sep; 122(5):7-17. PubMed ID: 20861583 [TBL] [Abstract][Full Text] [Related]
33. Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults. Vaughan BS; Wetzel MW; Kratochvil CJ Int Rev Psychiatry; 2008 Apr; 20(2):143-9. PubMed ID: 18386204 [TBL] [Abstract][Full Text] [Related]
34. A comparison of working memory profiles in school-aged children with Specific Language Impairment, Attention Deficit/Hyperactivity Disorder, Comorbid SLI and ADHD and their typically developing peers. Hutchinson E; Bavin E; Efron D; Sciberras E Child Neuropsychol; 2012; 18(2):190-207. PubMed ID: 21919558 [TBL] [Abstract][Full Text] [Related]
35. Contextual abnormalities of saccadic inhibition in children with attention deficit hyperactivity disorder. Cairney S; Maruff P; Vance A; Barnett R; Luk E; Currie J Exp Brain Res; 2001 Dec; 141(4):507-18. PubMed ID: 11810144 [TBL] [Abstract][Full Text] [Related]
36. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder]. Durukan I; Türkbay T; Cöngöloğlu A Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977 [TBL] [Abstract][Full Text] [Related]
37. Attention-deficit/hyperactivity disorder (ADHD) symptoms, anxiety symptoms, and executive functioning in emerging adults. Jarrett MA Psychol Assess; 2016 Feb; 28(2):245-50. PubMed ID: 26121381 [TBL] [Abstract][Full Text] [Related]
38. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder. Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569 [TBL] [Abstract][Full Text] [Related]
39. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069 [TBL] [Abstract][Full Text] [Related]
40. Association between attention-deficit/hyperactivity disorder and sleep impairment in adulthood: evidence from a large controlled study. Surman CB; Adamson JJ; Petty C; Biederman J; Kenealy DC; Levine M; Mick E; Faraone SV J Clin Psychiatry; 2009 Nov; 70(11):1523-9. PubMed ID: 19646365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]